FXR activation by CDCA (50 μM/L) and GW4064 (2 μM/L) suppresses serum deprivation-induced apoptosis in human liver cancer HepG2 cells by activating the ERK1/2 MAPK pathway. Here, NR1H4 is linked to liver cancer.